|本期目录/Table of Contents|

[1]中华医学会肝病学分会.肝硬化肝性脑病诊疗指南[J].传染病信息,2018,05:403-420.
 Chinese Society of Hepatology,Chinese Medical Association.Guidelines on the management of hepatic encephalopathy in cirrhosis[J].Infectious Disease Information,2018,05:403-420.
点击复制

肝硬化肝性脑病诊疗指南(PDF)

《传染病信息》[ISSN:1007-8134/CN:11-3886/R]

期数:
2018年05期
页码:
403-420
栏目:
特别报道
出版日期:
2018-10-30

文章信息/Info

Title:
Guidelines on the management of hepatic encephalopathy in cirrhosis
作者:
中华医学会肝病学分会
Author(s):
Chinese Society of Hepatology Chinese Medical Association
关键词:
肝硬化肝性脑病诊断治疗
Keywords:
 liver cirrhosis hepatic encephalopathy diagnosis therapy
分类号:
R575.2
DOI:
10.3969/j.issn.1007-8134.2018.05.003
文献标识码:
A
摘要:
-
Abstract:
-

参考文献/References


[1] Ferenci P, Lockwood A, Mullen K, et al. Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: finalreport of the working party at the 11th World Congresses ofGastroenterology, Vienna, 1998[J]. Hepatology, 2002,35(3):716-721.DOI: 10.1053/jhep.2002.31250.
[2] Dhiman RK, Saraswat VA, Sharma BK, et al. Minimal hepaticencephalopathy: consensus statement of a working party ofthe Indian National Association for Study of the Liver[J]. JGastroenterol Hepatol, 2010, 25(6):1029-1041. DOI: 10.1111/j.1440-1746.2010.06318.x.
[3] American Association for the Study of Liver Diseases, EuropeanAssociation for the Study of the Liver. Hepatic Encephalopathy inChronic Liver Disease: 2014 Practice Guideline by the EuropeanAssociation for the Study of the Liver and the American Associationfor the Study of Liver Diseases[J]. Journal of Hepatology, 2014,61(3):642-659. DOI: 10.1016/j.jhep.2014.05.042.
[4] 中华医学会消化病学分会, 中华医学会肝病学分会. 中国肝性脑病诊治共识意见(2013 年,重庆)[J]. 中华肝脏病杂志,2013,21(9):641-651. DOI: 10.3760/cma.j.issn.1007-3418.2013.09.001.Chinese Society of Gastroenterology and Chinese Societyof Hepatology, Chinese Medical Association. Consensus onthe diagnosis and treatment of hepatic encephalopathy inChina(Chongqing, 2013)[J]. Chin J Hepatol, 2013, 21(9):641-651. DOI:10.3760/cma.j.issn.1007-3418.2013.09.001.
[5] 林言,范燕萍. 肝硬化患者的神经心理测试及轻微型肝性脑病调查[J]. 中华肝脏病杂志,2011,19(1):65-66. DOI:10.3760/cma.j.issn.1007-3418.2011.01.020.Lin Y, Fan YP. The neuropsychologic tests and the minimalhepaticencephalopathy investigations in liver cirrhotic patients [J]. Chin J Hepatol, 2011, 19(1):65-66. DOI:10.3760/cma.j.issn.1007-3418.2011.01.020.
[6] 郭津生. 重视轻微型肝性脑病的流行病学及诊断与治疗[J]. 中华肝脏病杂志,2014,22(2):92-93. DOI: 10.3760/cma.j.issn.1007- 3418.2014.02.005.Guo JS. Epidemiology, diagnosis and treatment of minimal hepaticencephalopathy[J]. Chin J Hepatol, 2014, 22(2):92-93.DOI:10.3760/cma.j.issn.1007-3418.2014.02.005.
[7] Bajaj JS, O'Leary JG, Tandon P, et al. Hepatic Encephalopathy IsAssociated With Mortality in Patients With Cirrhosis Independent ofOther Extrahepatic Organ Failures[J]. Clin Gastroenterol Hepatol,2017 Apr; 15(4):565-574. e4.DOI: 10.1016/j.cgh.2016.09.157.
[8] Wang JY, Zhang NP, Chi BR, et al. Prevalence of minimal hepaticencephalopathy and quality of life evaluations in hospitalizedcirrhotic patients in China[J]. World J Gastroenterol, 2013,19(30):4984-4991. DOI: 10.3748/wjg.v19.i30.4984.
[9] Aldridge DR, Tranah EJ, Shawcross DL. Pathogenesis of hepaticencephalopathy: role of ammonia and systemic inflammation[J].J Clin Exp Hepatol, 2015, 5(Suppl 1):S7-S20. DOI: 10.1016/j.jceh.2014.06.004.
[10] 陆伦根. 肝性脑病;离我们并不遥远[J]. 中华消化杂志,2017,(8):508-512. DOI: 10.3760/cma.j.issn.0254-1432.2017.08.002.Lu LG. Hepatic encephalopathy: is not far away from us [J]. Chin J Dig, 2017, 37(8):508-512. DOI: 10.3760/cma.j.issn.0254-1432.2017.08. 002.
[11] Bajaj JS. The role of microbiota in hepatic encephalopathy[J].Gut Microbes, 2014, 5(3):397-403. DOI: 10.4161/gmic.28684.
[12] Wijarnpreecha K, Chesdachai S, Thongprayoon C, et al. Associationof Helicobacter pylori with the Risk of Hepatic Encephalopathy[J].Dig Dis Sci, 2017, 62(12):3614-3621. DOI: 10.1007/s10620-017-4834-1.
[13] Bajaj JS, Ridlon JM, Hylemon PB, et al. Linkage of gut microbiomewith cognition in hepatic encephalopathy[J]. Am J PhysiolGastrointest Liver Physiol, 2012, 302(1):G168-175. DOI: 10.1152/ajpgi.00190.2011.
[14] Janve VS, Hernandez CC, Verdier KM, et al. Epilepticencephalopathy de novo GABRB mutations impair GABAAreceptor function[J]. Ann Neurol, 2016, 79(5):806-825. DOI:10.1002/ana.24631. [Epub ahead of print]
[15] Kobtan AA, El-Kalla FS, Soliman HH, et al. Higher Grades andRepeated Recurrence of Hepatic Encephalopathy May Be Relatedto High Serum Manganese Levels[J]. Biol Trace Elem Res,2016, 169(2):153-158. DOI: 10.1007/s12011-015-0405-5.
[16] Butterworth RF. Neurosteroids in hepatic encephalopathy: Novelinsights and new therapeutic opportunities[J]. J Steroid BiochemMol Biol, 2016, 160:94-97. DOI: 10.1016/j.jsbmb.2015.11.006.
[17] Pereira K, Carrion AF, Martin P, et al. Current diagnosis andmanagement of post-transjugular intrahepatic portosystemic shuntrefractory hepatic encephalopathy. Liver Int. 2015, 35(12):2487-2494. DOI: 10.1111/liv.12956.
[18] Tsai CF, Chen MH, Wang YP, et al. Proton Pump InhibitorsIncrease Risk for Hepatic Encephalopathy in Patients WithCirrhosis in A Population Study[J]. Gastroenterology, 2017,152(1):134-141. DOI:10.1053/j.gastro.2016.09.007.
[19] Blei AT, Cordoba J. Hepatic Encephalopathy[J]. Am J Gastroenterol,2001,96(7):1968-1976. DOI: 10.1111/j.1572-0241.2001.03964.x.
[20] Bajaj JS, Cordoba J, Mullen KD, et al. Review article: the design ofclinical trials in hepatic encephalopathy--an International Societyfor Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN)consensus statement[J]. Aliment Pharmacol Ther, 2011,33(7):739-747. DOI: 10.1111/j.1365-2036.2011.04590.x.
[21] Sharma P, Sharma BC, Puri V, et al. Critical flicker frequency:diagnostic tool for minimal hepatic encephalopathy[J]. JHepatol, 2007,47(1):67–73. DOI: 10.1016/j.jhep.2007.02.022.
[22] Agrawal S, Umapathy S, Dhiman RK. Minimal hepaticencephalopathy impairs quality of life[J]. J Clin Exp Hepatol,2015, 5(Suppl 1):S42-48. DOI: 10.1016/j.jceh.2014.11.006.
[23] Wang AJ, Peng AP, Li BM, et al. Natural history of covert hepetaticencephalopathy: An observational study of 366 cirrhotic patient[s J].World J Gastroenterol, 2017, 23(34):6321-6329. DOI: 10.3748/wjg.v23.i34.6321.
[24] Lockwood AH. Blood ammonia levels and hepatic encephalopathy [J]. Metab Brain Dis, 2004, 19(3-4):345-349.
[25] Iwasa M, Sugimoto R, Mifuji-Moroka R, et al. Factors contributingto the development of overt encephalopathy in liver cirrhosispatients[J]. Metab Brain Dis, 2016, 31(5):1151-1156. DOI:10.1007/s11011-016-9862-6.
[26] Huang H, Wu T, Mao J, et al. CHI3L1 Is a Liver-Enriched,Noninvasive Biomarker That Can Be Used to Stage and DiagnoseSubstantial Hepatic Fibrosis[J]. Omics, 2015, 19(6):339-345.DOI:10.1089/omi.2015.0037.
[27] Yao M, Wang L, Leung PSC, et al. The Clinical Significanceof GP73 in Immunologically Mediated Chronic Liver Diseases:Experimental Data and Literature Review[J]. Clin Rev AllergyImmunol, 2018, 54(2):282-294. DOI: 10.1007/s12016-017-8655-y.
[28] Jeong JY, Jun DW, Bai D, et al. Validation of a Paper and PencilTest Battery for the Diagnosis of Minimal Hepatic Encephalopathyin Korea[J]. J korean Med Sci, 2017, 32(9):1484-1490. DOI:10.3346/jkms.2017.32.9.1484.
[29] Thomsen KL, Macnaughtan J, Tritto G, et al. Clinical andPathophysiological Characteristics of Cirrhotic Patients with Grade1 and Minimal Hepatic Encephalopathy[J]. PLoS One, 2016,11(1):e0146076. DOI: 10.1371/journal.pone.0146076.
[30] Gimenez-Garzo C, Garces JJ, Urios A, et al. The PHES batterydoes not detect all cirrhotic patients with early neurological deficits,which are different in different patients[J]. PLoS One, 2017,12(2):e0171211. DOI: 10.1371/journal.pone.0171211.
[31] 郝良成,胡阳黔,侯晓华. 年龄和受教育程度矫正的数字连接测试和数字符号测试在诊断轻微肝性脑病中的应用[J].中华肝脏病杂志,2015,23(7):533-537. DOI: 10.3760/cma.j.issn.1007-3418.2015.07.013.Hao LC, Hu YQ, Hou XH. Age- and education-corrected numberconnection test and digit symbol test in diagnosis of minimalhepatic encephalopathy[J]. Chin J Hepatol, 2015, 23(7):533-537. DOI:10.3760/cma.j.issn.1007-3418.2015.07.013.
[32] Wuensch T, Ruether DF, Zollner C, et al. Performancecharacterization of a novel electronic number connection test todetect minimal hepatic encephalopathy in cirrhotic patients[J].Eur J Gastroenterol Hepatol, 2017, 29(4):456-463. DOI: 10.1097/MEG.0000000000000806.
[33] Bajaj JS, Heuman DM, Sterling RK, et al. Validation ofEncephalApp, Smartphone-Based Stroop Test, for the Diagnosis ofCovert Hepatic Encephalopathy[J]. Clin Gastroenterol Hepatol,2015, 13(10):1828-1835.e1821. DOI: 10.1016/j.cgh.2014.05.011.
[34] 王月,石绣江,希尔娜依·阿不都黑力力,等. 临界闪烁频率诊断轻微肝性脑病的价值[J]. 中华肝脏病杂志,2013,21(7):546-547.DOI: 10.3760/cma.j.issn.1007-3418.2013.07.017.Wang Y, Shi XJ, Auduheilili XENY, et al. Critical flickerfrequency for the diagnosis of minimal hepatic encephalopathy [J]. Chin J Hepatol, 2013, 21(7):546-547. DOI: 10.3760/cma.j.issn.1007-3418.2013.07.017.
[35] 马千云,诸葛宇征. 临界视觉闪烁频率对轻微肝性脑病的诊断价值[J]. 临床肝胆病杂志,2012,28(7):559-561.Ma QY, Zhuge YZ. Diagnostic value of critical flicker frequency inminimal hepatic encephalopathy[J]. J Clin Hepatol, 2012, 28(7):559-561.
[36] Kircheis G, Hilger N, Haussinger D. Value of critical flickerfrequency and psychometric hepatic encephalopathy scorein diagnosis of low-grade hepatic encephalopathy[J].Gastroenterology, 2014, 146(4):961-969. DOI: 10.1053/j.gastro.2013.12.026.
[37] Ampuero J, Simon M, Montoliu C, et al. Minimal hepaticencephalopathy and critical flicker frequency are associatedwith survival of patients with cirrhosis[J]. Gastroenterology,2015,149(6):1483-1489. DOI: 10.1053/j.gastro.2015.07.067.
[38] Campagna F, Montagnese S, Ridola L, et al. The animal namingtest: An easy tool for the assessment of hepatic encephalopathy[J].Hepatology, 2017, 66(1):198-208. DOI: 10.1002/hep.29146.
[39] Urios A, Mangas-Losada A, Gimenez-Garzo C, et al. Alteredpostural control and stability in cirrhotic patients with minimalhepatic encephalopathy correlate with cognitive deficits[J].Liver Int, 2017, 37(7):1013-1022. DOI: 10.1111/liv.13345.
[40] Seo K, Jun DW, Kim JK, et al. Multi-Sensory IntegrationImpairment in Patients with Minimal Hepatic Encephalopathy[J].Sci Rep, 2017, 7(1):14947. DOI: 10.1038/s41598-017-15113-1.
[41] Guerit JM, Amantini A, Fischer C, et al. Neurophysiologicalinvestigations of hepatic encephalopathy: ISHEN practiceguidelines[J]. Liver Int, 2009, 29(6):789–796. DOI: 10.1111/j.1478-3231.2009.02030.x.
[42] 石彦斌,僧松娟,郭淼,等. 肝性脑病的磁共振及 CT 影像表现分析[J]. 中国实用神经疾病杂志,2016,19(19):127-128.DOI:10.3969/j.issn.1673-5110.2016.19.082.Shi YB, Seng SJ, Guo M, et al. Analysis of magnetic resonanceand CT imaging findings in hepatic encephalopathy[J]. ChineseJournal of Practical Neruous Diseases, 2016, 19(19):127-128.DOI:10.3969/j.issn.1673-5110.2016.19.082.
[43] Qi R, Zhang LJ, Zhong J, et al. Grey and white matter abnormalitiesin minimal hepatic encephalopathy: a study combining voxel-basedmorphometry and tract-based spatial statistics[J]. Eur Radiol,2013, 23(12):3370-3378. DOI: 10.1007/s00330-013-2963-2.
[44] Kale RA, Gupta RK, Saraswat VA, et al. Demonstration ofinterstitial cerebral edema with diffusion tensor MR imaging in typeC hepatic encephalopathy[J]. Hepatology, 2006, 43(4):698-706. DOI: 10.1002/hep.21114.
[45] Zheng G, Zhang LJ, Zhong J, et al. Cerebral blood flow measured byarterial-spin labeling MRI: a useful biomarker for characterizationof minimal hepatic encephalopathy in patients with cirrhosis [J]. Eur J Radiol, 2013, 82(11):1981-1988. DOI: 10.1016/j.ejrad.2013.06.002.
[46] Chen HJ, Chen QF, Yang ZT, et al. Aberrant topologicalorganization of the functional brain network associated with priorovert?hepatic encephalopathy in cirrhotic patients[J].BrainImaging Behav, 2018. DOI: 10.1007/s11682-018-9896-y. [Epubahead of print]
[47] Chen HJ, Chen QF, Liu J, et al. Aberrant salience network and itsfunctional coupling with default and executive networks in minimalhepatic encephalopathy: a resting-state fMRI study[J]. Sci Rep,2016, 6:27092. DOI: 10.1038/srep27092.
[48] 焦蕴,汤天宇,王训恒,等. 轻微型肝性脑病患者前后默认网络改变与神经认知损伤的关系[J]. 中华医学杂志,2016,96(5):334-338. DOI: 10.3760/cma.j.issn.0376-2491.2016.05.004.Jiao Y, Tang TY, Wang XH, et al. Anterior and posterior defaultmode networks impairments in minimal hepatic encephalopathy[J].Natl Med J Chin, 2016, 96(5):334-338.
[49] Suraweera D, Sundaram V, Saab S. Evaluation and Management ofHepatic Encephalopathy: Current Status and Future Directions[J].Gut Liver, 2016, 10(4):509-519. DOI: 10.5009/gnl15419.
[50] Shawcross DL, Dunk AA, Jalan R, et al. How to diagnose andmanage hepatic encephalopathy: a consensus statement onroles and responsibilities beyond the liver specialist[J]. EurJ Gastroenterol Hepatol, 2016, 28(2):146-152. DOI: 10.1097/MEG.0000000000000529.
[51] Hanai T, Shiraki M, Watanabe S, et al. Sarcopenia predicts minimalhepatic encephalopathy in patients with liver cirrhosis [J].Hepatol Res, 2017, 47(13):1359-1367. DOI: 10.1111/hepr.12873.
[52] NeSmith M, Ahn J, Flamm SL. Contemporary Understanding andManagement of Overt and Covert Hepatic Encephalopathy[J].Gastroenterol Hepatol (N Y), 2016,12(2):91-100.
[53] 阎明. 轻微型肝性脑病诊治方法的选择[J]. 临床肝胆病杂志,2016, 32(6):1092-1099.
[54] Scalzo SJ, Bowden SC, Ambrose ML, et al. Wernicke-Korsakoffsyndrome not related to alcohol use: a systematic review[J].J Neurol Neurosurg Psychiatry, 2015, 86(12):1362-1368. DOI:10.1136/jnnp-2014-309598.
[55] Phan AQ, Pacifici M, Esko JD. Advances in the pathogenesis andpossible treatments for multiple hereditary exostoses from the 2016international MHE conference[J]. Connect Tissue Res, 2018,59(1):85-98. DOI: 10.1080/03008207.2017.1394295.
[56] Liu A, Yoo ER, Siddique O, et al. Hepatic encephalopathy: whatthe multidisciplinary team can do[J]. J Multidiscip Healthc,2017, 10:113-119. DOI: 10.2147/JMDH.S118963.
[57] Goyal O, Sidhu SS, Kishore H. Minimal hepatic encephalopathy incirrhosis- how long to treat[J]. Ann Hepatol, 2017, 16(1):115-122. DOI: 10.5604/16652681.1226822.
[58] 丁惠国,徐小元,令狐恩强,等.《肝硬化门静脉高压食管胃静脉曲张出血的防治指南》解读[J]. 临床肝胆病杂志,2016,32(2):220-222. DOI: 10.3969/j.issn.1001-5256.2016.02.003.Ding HG, Xu XY, Linghu EQ, et al. Guidelines for preventionand treatment of esophageal variceal bleeding in cirrhotic portalhypertension[J]. J Clin Hepatol, 2016, 32(2):220-222.DOI:10.3969/ J.issn.1001-5256.2016.02.003.
[59] 中华医学会肝病学分会. 肝硬化腹水及其相关并发症诊治指南[J]. 中华肝脏病杂志,2017,25(9):664-677. DOI:10.3760/cma.j.issn.1007-3418.2017.09.006.Chinese Society of Hepatology, Chinese Medical Association.Guidelines on the management of ascites and complicationsin cirrhosis[J]. Chin J Hepatol, 2017, 25(9):664-677. DOI:10.3760/cma.j.issn.1007-3418.2017.09.006.
[60] Moratalla A, Ampuero J, Bellot P, et al. Lactulose reduces bacterialDNA translocation, which worsens neurocognitive shape in cirrhoticpatients with minimal hepatic encephalopathy[J]. Liver Int,2017, 37(2):212-223. DOI: 10.1111/liv.13200.

备注/Memo

备注/Memo:

[ 通信作者] 徐小元,E-mai: xiaoyuanxu6@163.com;段钟平, E-mail: duan2517@163.com
更新日期/Last Update: 2018-10-30